Beaulieu P - Search Results

1

Predictors of Pain Reduction Among Fibromyalgia Patients Using Medical Cannabis: A Long-Term Prospective Cohort Study.

Sotoodeh R, Waldman LE, Vigano A, Moride Y, Canac-Marquis M, Spilak T, Gamaoun R, Kalaba M, Hachem Y, Beaulieu P, Desroches J, Ware MA, Perez J, Shir Y, Fitzcharles MA, Martel MO. Sotoodeh R, et al. Among authors: beaulieu p. Arthritis Care Res (Hoboken). 2023 Jul;75(7):1588-1594. doi: 10.1002/acr.24985. Epub 2023 Feb 3. Arthritis Care Res (Hoboken). 2023. PMID: 35876631

2

Reassessment of the role of cannabinoids in the management of pain.

Beaulieu P, Ware M. Beaulieu P, et al. Curr Opin Anaesthesiol. 2007 Oct;20(5):473-7. doi: 10.1097/ACO.0b013e3282efd175. Curr Opin Anaesthesiol. 2007. PMID: 17873600 Review.

3

Medical cannabis: considerations for the anesthesiologist and pain physician.

Beaulieu P, Boulanger A, Desroches J, Clark AJ. Beaulieu P, et al. Can J Anaesth. 2016 May;63(5):608-24. doi: 10.1007/s12630-016-0598-x. Epub 2016 Feb 5. Can J Anaesth. 2016. PMID: 26850063 Review.

4

Opioids and cannabinoids interactions: involvement in pain management.

Desroches J, Beaulieu P. Desroches J, et al. Among authors: beaulieu p. Curr Drug Targets. 2010 Apr;11(4):462-73. doi: 10.2174/138945010790980303. Curr Drug Targets. 2010. PMID: 20017728 Review.

5

Cannabinoids for the treatment of pain: an update on recent clinical trials.

Ware M, Beaulieu P. Ware M, et al. Among authors: beaulieu p. Pain Res Manag. 2005 Autumn;10 Suppl A:27A-30A. doi: 10.1155/2005/847562. Pain Res Manag. 2005. PMID: 16237479 Review.

6

[The cannabinoid system and pain: a new therapeutic avenue?].

Desroches J, Beaulieu P. Desroches J, et al. Among authors: beaulieu p. Rev Med Suisse. 2008 Jun 18;4(162):1505-6, 1508-10, 1512-3. Rev Med Suisse. 2008. PMID: 18649597 Review. French.

7

The antinociceptive effects of intraplantar injections of 2-arachidonoyl glycerol are mediated by cannabinoid CB2 receptors.

Guindon J, Desroches J, Beaulieu P. Guindon J, et al. Among authors: beaulieu p. Br J Pharmacol. 2007 Mar;150(6):693-701. doi: 10.1038/sj.bjp.0706990. Epub 2006 Dec 18. Br J Pharmacol. 2007. PMID: 17179944 Free PMC article.

8

Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.

Desroches J, Charron S, Bouchard JF, Beaulieu P. Desroches J, et al. Among authors: beaulieu p. Neuropharmacology. 2014 Feb;77:441-52. doi: 10.1016/j.neuropharm.2013.10.006. Epub 2013 Oct 19. Neuropharmacology. 2014. PMID: 24148808

9

Pre-emptive antinociceptive effects of a synthetic cannabinoid in a model of neuropathic pain.

Guindon J, Desroches J, Dani M, Beaulieu P. Guindon J, et al. Among authors: beaulieu p. Eur J Pharmacol. 2007 Jul 30;568(1-3):173-6. doi: 10.1016/j.ejphar.2007.04.060. Epub 2007 May 22. Eur J Pharmacol. 2007. PMID: 17555742

10

Modulation of the anti-nociceptive effects of 2-arachidonoyl glycerol by peripherally administered FAAH and MGL inhibitors in a neuropathic pain model.

Desroches J, Guindon J, Lambert C, Beaulieu P. Desroches J, et al. Among authors: beaulieu p. Br J Pharmacol. 2008 Nov;155(6):913-24. doi: 10.1038/bjp.2008.322. Epub 2008 Aug 11. Br J Pharmacol. 2008. PMID: 18695638 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters